Zimmer Biomet Holdings, Inc. (NYSE: ZBH)

This investigation is for anyone who acquired securities in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) prior to November 5, 2025.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by failing to timely disclose to investors that the Company was experiencing weakness in demand for its products in the U.S. hip and knee markets.

On November 5, 2025, Zimmer released its third quarter 2025 financial results, reporting net sales of about $2 billion, due to “weakness in Latin America, Emerging Markets in Europe and non-core businesses.” The Company also reduced the top end of its full-year organic revenue growth forecast from 4.5% to 4.0%, due, in part, to “continued weakness in restorative therapies,” and “the modest slowdown in the U.S. revision market for both hips and knees persisting throughout the rest of 2025.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) prior to November 5, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.